SCHEMBL23958880

SCHEMBL23958880

C=C(F)/C(=N\C)c1ccc(F)c(F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.45
CES1 P23141 2/20 0.45
RAB9A P51151 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CHRNA1 P02708 1/20 0.36
CHRNG P07510 1/20 0.36
CHRNB1 P11230 1/20 0.36
CHRNB2 P17787 1/20 0.36
SLC6A2 P23975 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA4 P43681 1/20 0.36
SLC6A3 Q01959 1/20 0.36
CHRND Q07001 1/20 0.36
MAOA P21397 2/20 0.35
MAOB P27338 2/20 0.35
PLA2G7 Q13093 1/20 0.35
POLB P06746 1/20 0.33
KCNQ3 O43525 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23958873 0.80 CES2 (0.41) CES2CES1RAB9AMEN1KMT2A
SCHEMBL23958719 0.80 CES2 (0.38) CES2CES1MAOAMAOBSMN1; SMN2
SCHEMBL6963321 0.73 CES2 (0.54) CES2CES1RAB9AMEN1KMT2A
SCHEMBL23959002 0.72 CES2 (0.44) CES2CES1PTGS2
SCHEMBL20938010 0.69 CES2 (0.54) CES2CES1RAB9AMEN1KMT2A
SCHEMBL23905448 0.68 CES2 (0.44) CES2CES1RAB9AMEN1KMT2A
SCHEMBL16954373 0.68 CES2 (0.58) CES2CES1RAB9AMEN1KMT2A
SCHEMBL24849873 0.67 CES2 (0.42) CES2CES1RAB9AMEN1KMT2A
SCHEMBL16953066 0.66 CES2 (0.56) CES2CES1RAB9AMEN1KMT2A
SCHEMBL9617322 0.66 CES2 (0.70) CES2CES1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021214136-A1 RSV INHIBITING 3-SUBSTITUTED QUINOLINE AND CINNOLINE DERIVATIVES Janssen Sciences Ireland Unlimited Company (IE) 2021-10-28 WO disclosed